Marksans Pharma Ltd.

View in App
172.15 +5.00 ▲3.0%

26 April 2024, 04:02:42 PM
Volume: 2,110,794

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.marksanspharma.com
Market Cap 7,780.82 Cr.
Enterprise Value(EV) 6,937.98 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.00 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 24.52 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 43.22 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.97 Calculated using Price: 171.70
Dividend Yield 0.29 Period Ending 2023-03
No. of Shares Subscribed 45.32 Cr. 453,163,746 Shares
FaceValue 1
About Marksans Pharma Ltd.
Marksans Pharma, incorporated in 1992, was a wholly-owned subsidiary of Glenmark Pharmaceuticals. It became a separate entity in March 2003 and the name was changed to Marksans Pharma in 2005.

Marksans Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Marksans Pharma Ltd. Performance

View details >>
1 Day
+2.99%
1 Week
+1.00%
1 Month
+18.36%
3 Month
+17.95%
6 Month
+69.61%
1 Year
+112.27%
2 Year
+216.16%
5 Year
+612.84%
10 Year
+643.63%

Marksans Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 45.15 20.45 2.59 7.92 15.88 20.49 31.33 18.72 18.59
Return on Capital Employed (%) 44.64 23.16 4 10.6 18.51 25.57 39.76 23.82 22.89
Return on Assets (%) 19.21 11.86 1.54 4.83 10.49 14.17 22.4 12.94 13.66

Marksans Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 380 454 433 471 542 636 887 1,202 1,745 1,876
Non Curr. Liab. 1 -2 16 16 17 24 24 57 94 84
Curr. Liab. 286 259 296 235 233 229 299 380 365 333
Minority Int. 8 8 6 10 10 13 19 21 20 21
Equity & Liab. 676 720 752 731 802 902 1,228 1,660 2,224 2,314
Non Curr. Assets 167 280 268 280 271 308 325 435 525 610
Curr. Assets 509 440 484 451 531 594 903 1,225 1,700 1,704
Misc. Exp. not W/O
Total Assets 676 720 752 731 802 902 1,228 1,660 2,224 2,314

Marksans Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 797 893 767 913 1,000 1,134 1,376 1,491 1,852 2,103
Other Income 12 13 19 8 5 0 7 42 59 45
Total Income 809 906 786 921 1,005 1,135 1,383 1,533 1,911 2,148
Total Expenditure -621 -761 -734 -834 -868 -942 -1,037 -1,232 -1,513 -1,645
PBIDT 188 145 52 87 137 193 346 301 399 503
Interest -16 -10 -7 -10 -10 -9 -8 -8 -9 -9
Depreciation -16 -28 -30 -27 -23 -27 -36 -45 -52 -67
Taxation -44 -24 -4 -14 -24 -36 -64 -61 -72 -107
Exceptional Items
PAT 112 83 11 36 80 121 239 187 265 320
Minority Interest -3 -4 -3 -3 -4 -4 -3 -2 1 -3
Share Associate
Other Related Items
Consolidated Net Profit 109 79 9 33 76 117 236 185 266 317
Adjusted EPS 3 2 0 1 2 3 6 5 6 7

Marksans Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 65 155 31 14 50 27 233 179 99 237
Cash Fr. Inv. -4 -33 -123 -21 -39 -13 -60 -45 -84 -259
Cash Fr. Finan. -29 17 -58 -3 3 -21 -114 -15 80 198
Net Change 31 138 -150 -10 15 -7 60 118 94 176
Cash & Cash Eqvt 47 185 35 25 40 33 94 212 206 382

Marksans Pharma Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 48.25 48.25 48.60 49.00 43.85 43.85 43.85 43.85 43.85
Public 51.75 51.75 51.40 51.00 56.15 56.15 56.15 56.15 56.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Marksans Pharma Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Press Release
Marksans Pharma Limited has informed the Exchange regarding a press release dated April 18, 2024, titled USFDA inspection at Company's manufacturing facility in Verna, Goa, India.
Tue, 09 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Marksans Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mon, 08 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
MARKSANS PHARMA LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation

Marksans Pharma Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Marksans Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,506.55 -0.9%
Cipla Ltd. 113,471.29 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,252.10 +0.5%
Divi's Laboratories Ltd. 101,959.84 4,016.35 +4.5%
Zydus Lifesciences Ltd. 95,944.41 947.40 -0.4%
Mankind Pharma Ltd. 95,926.91 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,258.60 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.60 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,258.60 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.38 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,258.60 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,258.60 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,258.60 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,258.60 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,258.60 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,258.60 -2.0%

Marksans Pharma Ltd. FAQ's

What is Marksans Pharma share price?
Can I buy Marksans Pharma shares now?
What is the Dividend Yield of Marksans Pharma?
What is the Market Cap of Marksans Pharma?
What are the key metrics to analyse Marksans Pharma?
What is the 52 Week High and Low of Marksans Pharma?
What is the trend of Marksans Pharma share price?